HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minghui Wang Selected Research

Brain Diseases (Brain Disorder)

1/2022Progressive multifocal leukoencephalopathy and peripheral neuropathy in a patient with Good's syndrome.
7/2004Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Minghui Wang Research Topics

Disease

70Neoplasms (Cancer)
08/2022 - 03/2002
14Infections
01/2022 - 12/2002
14Ovarian Neoplasms (Ovarian Cancer)
01/2018 - 08/2002
13Alzheimer Disease (Alzheimer's Disease)
01/2022 - 11/2018
10Lung Neoplasms (Lung Cancer)
08/2022 - 01/2016
10Breast Neoplasms (Breast Cancer)
07/2022 - 01/2005
8Esophageal Squamous Cell Carcinoma
01/2022 - 01/2013
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2021 - 04/2012
6Carcinoma (Carcinomatosis)
01/2021 - 01/2008
5Carcinogenesis
04/2021 - 01/2013
5Neoplasm Metastasis (Metastasis)
01/2020 - 03/2013
5Adenocarcinoma of Lung
01/2020 - 02/2016
4Fibrosis (Cirrhosis)
06/2021 - 10/2002
4Neuroinflammatory Diseases
03/2021 - 01/2019
4Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 04/2009
3Glioma (Gliomas)
08/2022 - 04/2006
3Bacterial Infections (Bacterial Infection)
12/2020 - 12/2019
3Amyloid Plaque
10/2020 - 11/2017
3Prostatic Neoplasms (Prostate Cancer)
01/2016 - 01/2011
3Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2004 - 08/2004
2Osteosarcoma (Osteogenic Sarcoma)
02/2022 - 02/2003
2Brain Diseases (Brain Disorder)
01/2022 - 07/2004
2Tauopathies
12/2021 - 01/2019
2Hemorrhage
10/2021 - 06/2021
2Cardiotoxicity
03/2021 - 10/2020
2Adenocarcinoma
01/2021 - 01/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 10/2003
2Obesity
01/2021 - 01/2020
2Brain Neoplasms (Brain Tumor)
01/2021 - 04/2006
2Neurodegenerative Diseases (Neurodegenerative Disease)
12/2020 - 06/2018
2Inflammation (Inflammations)
10/2020 - 01/2020
2Hypoxia (Hypoxemia)
01/2020 - 08/2016
2Hypertrophy
01/2020 - 01/2019
2Brain Ischemia (Cerebral Ischemia)
01/2020 - 01/2019
2Schizophrenia (Dementia Praecox)
11/2019 - 04/2016
2Hepatocellular Carcinoma (Hepatoma)
06/2019 - 01/2018
2Amyloidosis
01/2019 - 01/2019
2Atherosclerosis
01/2019 - 12/2015
2Triple Negative Breast Neoplasms
01/2018 - 11/2016
2Cardiovascular Diseases (Cardiovascular Disease)
12/2015 - 06/2014
2Colonic Neoplasms (Colon Cancer)
07/2013 - 04/2009
2Cicatrix (Scar)
07/2004 - 08/2003
2Melanoma (Melanoma, Malignant)
04/2004 - 04/2004
1Encephalitis (Encephalitis, Rasmussen)
08/2022
1COVID-19
05/2022

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
08/2022 - 04/2004
9Biomarkers (Surrogate Marker)IBA
08/2022 - 01/2017
9Pharmaceutical PreparationsIBA
01/2022 - 07/2004
7Long Noncoding RNAIBA
02/2022 - 08/2016
7Biological ProductsIBA
01/2020 - 10/2003
7Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA
06/2008 - 09/2003
7LuciferasesIBA
06/2008 - 03/2004
7SurvivinIBA
11/2006 - 04/2004
6Anti-Bacterial Agents (Antibiotics)IBA
08/2021 - 01/2018
6MicroRNAs (MicroRNA)IBA
04/2019 - 01/2013
6Messenger RNA (mRNA)IBA
04/2019 - 09/2004
5RNA (Ribonucleic Acid)IBA
05/2022 - 11/2016
5Therapeutic UsesIBA
01/2021 - 06/2004
5Amyloid (Amyloid Fibrils)IBA
01/2021 - 11/2017
5Complement System Proteins (Complement)IBA
01/2020 - 01/2017
5IntegrinsIBA
03/2013 - 05/2003
4ErbB Receptors (EGF Receptor)IBA
01/2020 - 02/2016
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2019 - 10/2003
4adenovirus receptorIBA
02/2012 - 08/2002
3Apolipoprotein E4IBA
01/2022 - 12/2020
3Circular RNAIBA
01/2022 - 11/2019
3Antimicrobial Cationic PeptidesIBA
01/2021 - 12/2019
3DNA (Deoxyribonucleic Acid)IBA
10/2020 - 09/2014
3Secretory Leukocyte Peptidase InhibitorIBA
02/2005 - 11/2004
2Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2022 - 02/2016
2Amino AcidsFDA Link
01/2022 - 01/2020
2Peptides (Polypeptides)IBA
01/2022 - 11/2017
2OsteocalcinIBA
06/2021 - 02/2003
2CalciumIBA
06/2021 - 01/2018
2CurcuminIBA
03/2021 - 12/2020
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2019
2LipidsIBA
01/2021 - 05/2012
2Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
01/2020 - 04/2009
2IronIBA
01/2020 - 07/2004
2human ERBB2 proteinIBA
01/2020 - 11/2019
2Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2020 - 01/2019
2AfatinibIBA
01/2020 - 11/2019
2ElementsIBA
01/2019 - 10/2003
2Phosphotransferases (Kinase)IBA
01/2019 - 01/2019
2Small Interfering RNA (siRNA)IBA
08/2016 - 01/2008
2Epidermal Growth Factor (EGF)IBA
02/2016 - 08/2003
2Antineoplastic Agents (Antineoplastics)IBA
06/2014 - 08/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 11/2004
2Capsid Proteins (Capsid Protein)IBA
02/2012 - 04/2010
2Neutralizing AntibodiesIBA
12/2002 - 08/2002
1Leucine (L-Leucine)FDA Link
08/2022
1Docetaxel (Taxotere)FDA Link
07/2022
1Tyrosine Kinase InhibitorsIBA
07/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2022
1liposomal doxorubicin (Doxil)FDA Link
07/2022
1pyrotinibIBA
07/2022

Therapy/Procedure

23Therapeutics
06/2021 - 03/2002
4Drug Therapy (Chemotherapy)
08/2016 - 06/2008
2Neoadjuvant Therapy
07/2022 - 12/2012
2Transplantation
09/2004 - 10/2002